ABCSG P02

A prospective randomized phase II trial of FOLFIRINOX alone versus FOLFIRINOX followed by radiochemotherapy in patients with locally advanced, primarily inoperable pancreatic cancer.

Start: 05/2017
Coordinating Investigator: Schindl, Martin; Vienna
Kornek, Gabriela; Vienna
Döller, Carmen; Graz
Sample size: 112
Design:
(Click to enlarge)
ABCSG P02